Where can I buy Eton Pharmaceuticals stock?
Shares of ETON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Eton Pharmaceuticals' stock price today?
What does Eton Pharmaceuticals's P/E ratio mean?
The P/E ratio of Eton Pharmaceuticals is -8.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Eton Pharmaceuticals is -8.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
How did peloton's $750 million borrowing stem the tide?
To stem the tide until then, it entered an agreement to borrow $750 million. It also has $1. 4 billion of inventory on hand, so a boost in sales could make things monumentally easier on management going forward. Peloton made price changes on April 14 to help demand, which is on pace to boost sales by $40 million monthly.
Why is Eton stock down?
Eton's stock falls after FDA questions application for methanol poisoning therapy.
Will Eton stock go up?
Eton Pharmaceuticals Inc (NASDAQ:ETON) The 2 analysts offering 12-month price forecasts for Eton Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 11.00 and a low estimate of 10.00. The median estimate represents a +213.43% increase from the last price of 3.35.
Is Eton a good stock to buy?
Eton Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Who owns Eton pharmaceuticals?
The Vanguard Group, Inc.
How much does it cost to go to Eton?
Eton CollegeColour(s)Eton blueSongCarmen EtonensePublicationThe Chronicle Etonomics The LexiconSchool fees£48,501 per year US$68,244 per year27 more rows
Did Eton get FDA approval?
The FDA did not approve Eton Pharmaceuticals' eye drop for allergic conjunctivitis, serving up a complete response letter that raised “no concerns” about the clinical data in the drug's application.
What is the meaning of Eton?
British Dictionary definitions for Eton Eton. / (ˈiːtən) / noun. a town in S England, in Windsor and Maidenhead unitary authority, Berkshire, near the River Thames: site of Eton College, a public school for boys founded in 1440.
Is ETON stock a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eton Pharmaceuticals in the last twelve months. There are currently 2 buy...
Will Eton Pharmaceuticals' stock price go up in 2022?
2 Wall Street research analysts have issued 12 month price objectives for Eton Pharmaceuticals' stock. Their forecasts range from $11.00 to $11.00....
How has Eton Pharmaceuticals' stock performed in 2022?
Eton Pharmaceuticals' stock was trading at $4.29 at the beginning of the year. Since then, ETON shares have decreased by 29.4% and is now trading a...
When is Eton Pharmaceuticals' next earnings date?
Eton Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for...
How were Eton Pharmaceuticals' earnings last quarter?
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) issued its quarterly earnings results on Wednesday, March, 16th. The company reported $0.04 earnings per s...
Who are Eton Pharmaceuticals' key executives?
Eton Pharmaceuticals' management team includes the following people: Mr. Sean E. Brynjelsen , Pres, CEO & Director (Age 50, Pay $692.12k) ( Link...
Who are some of Eton Pharmaceuticals' key competitors?
Some companies that are related to Eton Pharmaceuticals include Aerovate Therapeutics (AVTE) , Verona Pharma (VRNA) , Ocular Therapeutix (OCUL)...
What other stocks do shareholders of Eton Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Eton Pharmaceuticals investors own include Sorrento Therap...
When did Eton Pharmaceuticals IPO?
(ETON) raised $22 million in an IPO on Wednesday, November 14th 2018. The company issued 3,600,000 shares at $6.00 per share. National Securities C...
When will Eton report results?
Is the FDA pending the PAI?
03, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2021 financial and operating results on Monday, August 16, 2021.
Is Eton Pharmaceuticals a big mover?
A Pre-Approval Inspection (PAI) of the product’s European contract manufacturer is pending due to what the company believes are COVID-related travel restrictions.
What is the FDA's response letter for Eton?
Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
What factors are important in biotech stocks?
Eton Pharmaceuticals (ETON) received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) related to a dehydrated alcohol injection for treating methanol poisoning. After reviewing the NDA, the FDA has declined to approve it in its present form. Eton shares fell about 16.8% to close at $7.06 on May 28. Amid COVID-19 associated travel restrictions, a pre-approval inspection of the drug’s contract manufacturer in Europe is yet to be c
Is Eton Pharmaceuticals a big mover?
For biotech stocks, factors including clinical trial data, regulatory decisions, and successful commercialization of drugs are sometimes more significant than earnings results in evaluating the prospects of the company. Therefore, any positive update could be the catalyst that results in the ballooning of shares.
Referenced Symbols
Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
More On MarketWatch
Shares of Eton Pharmaceuticals Inc. ETON, +2.65% tumbled 20.0% in premarket trading on Friday after the company said the Food and Drug Administration issued a complete response letter, saying it cannot approve Eton's application for its methanol poisoning treatment in his current form.
About the Author
Barron's: Peloton Stock Had Its Best Day Ever. It’s About More Than a New CEO.
